Concepedia

K. Sang-We

KS

Statistics

Publications

1

Citations

60

H-Index

1

Active since

2022

Affiliations

Asan Medical Center(Current)

K. Sang-We is an author at Asan Medical Center specializing in medicine, cancer pharmacology, and oncology.

Publications per year

2022–2022

1

Publications

1

LBA55 Trastuzumab deruxtecan (T-DXd) in patients (Pts) with HER2-mutant metastatic non-small cell lung cancer (NSCLC): Interim results from the phase 2 DESTINY-Lung02 trial

Keiko Goto, K. Sang-We, Takafumi Kubo et al. · Annals of Oncology · 2022 · 60 citations · Full text

Medicine, Oncology, Pharmacology +17

1–1 of 1